Albany, OR – According to filings with the U.S. Securities and Exchange Commission, Lazarus 3D is raising $13,296,500.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Jacques Zaneveld played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Lazarus 3D

Lazarus 3D has developed the worlds first FDA cleared technology that allows physicians to rehearse their case on a copy of the patient before the real operation. These preoperative surgical rehearsal or PRE-SURE models allow surgeons to perfect their surgical plan before the real thing so that they can operate with confidence. Each patient is unique, we strive to establish personalized medicine solutions for patients and physicians alike. Our Pre-Sure (PRE-operative SUrgical REhearsal) models are made with soft silicones and hydrogels that mimic human tissue making them ideal for practicing incisions and sutures. They allow you to practice on a 3D printed, patient-specific replica before operating. Personalized patient care improves patient experience, maximizes safety and drives better outcomes.

To learn more about Lazarus 3D, visit http://www.lazarus3d.com/

Contact:
Jacques Zaneveld, Chief Executive Officer
541-760-1805
https://www.linkedin.com/in/jacques-zaneveld/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved